GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Accelrys, Inc. (ACCL) [hlAlert]

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting
angiotensin and endothelin receptor antagonist for hypertension and diabetic kidney disease for which Phase 1 clinical trials are underway. Other internal proprietary programs address primarily immunoregulation. Pharmacopeia's collaborative efforts have resulted in a portfolio that includes one partnered program currently in Phase 2 clinical trials targeting chronic obstructive pulmonary disease and four partnered programs in Phase 1 clinical trials targeting rheumatoid arthritis, oncology, metabolic and inflammatory diseases. Four additional partnered compounds are in preclinical development.
( Total: 7 Current Stock Recommendations )
Accelrys, Inc.   (7)
Hold 29% Buy 71%
Related companies
DARA BIOSCIENCES   (2)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
Heron Therapeutics ...   (7)
Buy 100%
CELSION CORP   (5)
Buy 100%
China Biologic ...   (3)
Buy 100%
China Pharma   (2)
Buy 100%
BioSpecifics ...   (4)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Oncogenex ...   (8)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
11/7/2008  
Buy
up  31.13 %
8/6/2010  
Buy
up  31.13 %
3/26/2012  
Buy
up  31.13 %
6/15/2012  
Buy
up  31.13 %
6/27/2012  
Buy
up  31.13 %
1/30/2014  
Hold
  
1/31/2014  
Hold
  

* As of 10/17/2014 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy